Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie J Estcourt

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
European Journal of Immunology|October 26, 2005
Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell helpMarie J Estcourt, Andrew J McMichael, Tomás Hanke
Immunological Reviews|July 6, 2004
DNA vaccines against human immunodeficiency virus type 1Marie J Estcourt, Andrew J McMichael, Tomás Hanke
European Journal of Immunology|September 7, 2005
Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responsesMarie J Estcourt, Sven Létourneau, Andrew J McMichael, et al.
International Immunology|December 26, 2001
Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte populationMarie J Estcourt, Alistair J Ramsay, Andrew Brooks, et al.
Communications Medicine|March 14, 2026
Developing a general research framework for long COVID using causal modellingGladymar Pérez Chacón, Steven Mascaro, Marie J Estcourt, et al.
Journal of Virology|November 12, 2005
Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimenNatasha Larke, Aileen Murphy, Christoph Wirblich, et al.
The Cochrane Database of Systematic Reviews|October 25, 2021
Whole-cell pertussis vaccine in early infancy for the prevention of allergy in childrenGladymar Perez Chacon, Jessica Ramsay, Christopher G Brennan-Jones, et al.
Trials|February 8, 2022
Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine scheduleJames A Totterdell, Gladymar Perez Chacon, Marie J Estcourt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 5, 2024
Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort StudyGladymar Pérez Chacón, Parveen Fathima, Mark Jones, et al.
Plos One|October 4, 2023
Association between pertussis vaccination in infancy and childhood asthma: A population-based record linkage cohort studyGladymar Pérez Chacón, Parveen Fathima, Mark Jones, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Journal of Immunology|October 26, 2005
Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell helpMarie J Estcourt, Andrew J McMichael, Tomás Hanke
Immunological Reviews|July 6, 2004
DNA vaccines against human immunodeficiency virus type 1Marie J Estcourt, Andrew J McMichael, Tomás Hanke
European Journal of Immunology|September 7, 2005
Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responsesMarie J Estcourt, Sven Létourneau, Andrew J McMichael, et al.
International Immunology|December 26, 2001
Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte populationMarie J Estcourt, Alistair J Ramsay, Andrew Brooks, et al.
Communications Medicine|March 14, 2026
Developing a general research framework for long COVID using causal modellingGladymar Pérez Chacón, Steven Mascaro, Marie J Estcourt, et al.
Journal of Virology|November 12, 2005
Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimenNatasha Larke, Aileen Murphy, Christoph Wirblich, et al.
The Cochrane Database of Systematic Reviews|October 25, 2021
Whole-cell pertussis vaccine in early infancy for the prevention of allergy in childrenGladymar Perez Chacon, Jessica Ramsay, Christopher G Brennan-Jones, et al.
Trials|February 8, 2022
Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine scheduleJames A Totterdell, Gladymar Perez Chacon, Marie J Estcourt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 5, 2024
Infant Whole-Cell Versus Acellular Pertussis Vaccination in 1997 to 1999 and Risk of Childhood Hospitalization for Food-Induced Anaphylaxis: Linked Administrative Databases Cohort StudyGladymar Pérez Chacón, Parveen Fathima, Mark Jones, et al.
Plos One|October 4, 2023
Association between pertussis vaccination in infancy and childhood asthma: A population-based record linkage cohort studyGladymar Pérez Chacón, Parveen Fathima, Mark Jones, et al.
Pageof 2